EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of concomitant use of yokukansan on steady‐state blood concentrations of donepezil and risperidone in real‐world clinical practice

Junji Saruwatari iD, Tetsuya Kaneko, Tsukasa Murata iD, Haruka Narise, Sawa Kugimoto, Eri Nishimura, Natsuki Tetsuka, Misaki Ando, Momo Oi, Masako Ota, Nayumi Hamada, Keiichiro Kaneda und 8 weitere

Neuropsychopharmacology Reports · 2024

DOI: 10.1002/npr2.12459 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropsychopharmacology Reports, 2024. Verfasst von Junji Saruwatari und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan. Hauptthemen laut MEDLINE: Risperidone, Donepezil, Drugs, Chinese Herbal, Schizophrenia. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tsumura & Co..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Yokukansan is one of the most frequently used herbal medicines that can improve the behavioral and psychological symptoms of dementia. In this exploratory study, we investigated whether yokukansan affects the steady‐state blood concentrations of donepezil, risperidone, and the major metabolites of both drugs in a real‐world clinical setting.

Methods

A non‐randomized, open‐label, single‐arm study examining drug–drug interactions was conducted. Fifteen dementia patients taking donepezil for at least 4 weeks and eight schizophrenia patients taking risperidone for at least 2 weeks were orally administered 2.5 g of yokukansan three times a day before or between meals, and blood samples were collected before and 8 weeks after starting co‐treatment with yokukansan. Plasma concentrations of donepezil, risperidone, and each metabolite were measured using high‐performance liquid chromatography–tandem mass spectrometry and compared before and after the 8‐week administration of yokukansan.

Results

The plasma concentrations of donepezil and its metabolites (6‐ O ‐desmethyl‐donepezil, 5‐ O ‐desmethyl‐donepezil, and donepezil‐ N ‐oxide), risperidone, and its metabolite paliperidone did not differ before and after the 8‐week treatment with yokukansan.

Conclusions

The findings of this study show that the concomitant use of yokukansan may have little clinical impact on the steady‐state blood levels of donepezil and risperidone in patients with dementia or schizophrenia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RisperidoneDonepezilDrugs, Chinese HerbalSchizophreniaAntipsychotic AgentsHumansMaleFemaleAgedDementiaMiddle AgedPiperidinesIndansAged, 80 and overHerb-Drug Interactions

Stichwörter der Autor:innen

Kampodrug interactionsherb‐drug interactionsmetabolismpharmacokinetics

Substanzen

RisperidoneDonepezilDrugs, Chinese HerbalYi-Gan SanAntipsychotic AgentsPiperidinesIndans

Autor:innen und Institutionen

  • Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.
  • Department of Pharmacy, Kumamoto University Hospital, Kumamoto, Japan.
  • Kumamoto Seimei Hospital, Kumamoto, Japan.
  • Department of Clinical Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.
  • Department of Psychiatry, School of Medicine, Dokkyo Medical University, Tochigi, Japan.

ORCID-Profile: Junji Saruwatari, Tsukasa Murata, Kazutaka Oda, Hirofumi Jono, Norio Yasui-Furukori

Förderung

  • Tsumura & Co.

Zitieren

APA

Saruwatari, J., Kaneko, T., Murata, T., Narise, H., Kugimoto, S., Nishimura, E., Tetsuka, N., Ando, M., Oi, M., Ota, M., Hamada, N., Kaneda, K., Furusho, S., Sakamoto, M., Kajiwara-Morita, A., Oda, K., Oniki, K., Ueda, K., Jono, H., & Yasui-Furukori, N. (2024). Effect of concomitant use of yokukansan on steady‐state blood concentrations of donepezil and risperidone in real‐world clinical practice. Neuropsychopharmacology Reports. https://doi.org/10.1002/npr2.12459

Vancouver

Saruwatari J, Kaneko T, Murata T, Narise H, Kugimoto S, Nishimura E, et al. Effect of concomitant use of yokukansan on steady‐state blood concentrations of donepezil and risperidone in real‐world clinical practice. Neuropsychopharmacology Reports. 2024. doi:10.1002/npr2.12459

BibTeX
@article{Saruwatari2024,
  author = {Saruwatari, Junji and Kaneko, Tetsuya and Murata, Tsukasa and Narise, Haruka and Kugimoto, Sawa and Nishimura, Eri and Tetsuka, Natsuki and Ando, Misaki and Oi, Momo and Ota, Masako and Hamada, Nayumi and Kaneda, Keiichiro and Furusho, Shiro and Sakamoto, Masakatsu and Kajiwara-Morita, Ayami and Oda, Kazutaka and Oniki, Kentaro and Ueda, Keishi and Jono, Hirofumi and Yasui-Furukori, Norio},
  title = {Effect of concomitant use of yokukansan on steady‐state blood concentrations of donepezil and risperidone in real‐world clinical practice},
  journal = {Neuropsychopharmacology Reports},
  year = {2024},
  doi = {10.1002/npr2.12459}
}
Kostenlos starten →